PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Laboratory Sciences, Khomein University of Medical Sciences, Khomein, Iran.\', \'Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.\', \'Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.\', \'Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.\', \'Department of Medical Laboratory Sciences, Faculty of Paramedicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.\', \'Department of Paramedical Sciences, Gonabad University of Medical Sciences, Gonabad, Iran.\', \'Department of Anatomical Science, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran.\', \'Department of Anatomical Sciences, School of Medicine, Qom University of Medical Sciences, Qom, Iran.\', \'Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 137210.3390/biom11091372
?:hasPublicationType
?:journal
  • Biomolecules
is ?:pmid of
?:pmid
?:pmid
  • 34572585
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.552
?:rankingScore_hIndex
  • 28
?:title
  • The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all